Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain

Journal of Nuclear Medicine

Volumn 52, Issue 4, 2011, Pages 600-607

  Jacobson, Orit ^a   Weiss, Ido D ^b   Niu, Gang ^a   Balboni, Gianfranco ^c   Congiu, Cenzo ^c   Onnis, Valentina ^c   Kiesewetter, Dale O ^a   Lattanzi, Roberta ^d   Salvadori, Severo ^e   Chen, Xiaoyuan ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF FERRARA   (Italy)

Author keywords

18F; Inflammation; Positron emission tomography (PET); Prokineticin receptor

Indexed keywords

ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; FLUORINE 18; FLUOROBENZOATE F 18; FLUORODEOXYGLUCOSE F 18; G PROTEIN COUPLED RECEPTOR; N [2 [5 (4 FLUOROBENZYL) 1 (4 METHOXYBENZYL) 4,6 DIOXO 1,4,5,6 TETRAHYDRO [1,3,5]TRIAZIN 2 YLAMINO] ETHYL] GUANIDINE F 18; N' [2 [5 (4 FLUOROBENZYL) 1 (4 METHOXYBENZYL) 4,6 DIOXO 1,4,5,6 TETRAHYDRO [1,3,5]TRIAZIN 2 YLAMINO] ETHYL] GUANIDINE; PROKINETICIN 2; PROKINETICIN RECEPTOR 1; PROKINETICIN RECEPTOR 1 ANTAGONIST; PYRUVALDEHYDE BIS(4 METHYL 3 THIOSEMICARBAZONE) CU 64; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG SYNTHESIS; DRUG UPTAKE; GASTROINTESTINAL TRACT; INFLAMMATION; LIPOPHILICITY; MOLECULAR IMAGING; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND; SIGNAL NOISE RATIO; UPREGULATION;

ANIMALS; BINDING, COMPETITIVE; BIOLOGICAL MARKERS; CHO CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRICETINAE; CRICETULUS; FLUORINE RADIOISOTOPES; FOOT; GUANIDINES; INDICATORS AND REAGENTS; INFLAMMATION; ISOTOPE LABELING; MICE; MICE, INBRED C57BL; MOLECULAR WEIGHT; PAIN; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, G-PROTEIN-COUPLED; TISSUE DISTRIBUTION; TRIAZINES;

EID: 79954591399     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.084772     Document Type: Article

References (38)

1. Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H, Zhou QY. Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J Biol Chem. 2002;277:19276-19280. (Pubitemid 34967431)
2. Masuda Y, Takatsu Y, Terao Y, et al. Isolation and identification of EG-VEGF/ prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Biochem Biophys Res Commun. 2002;293:396-402. (Pubitemid 34694220)
3. Soga T, Matsumoto S, Oda T, et al. Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta. 2002;1579:173-179. (Pubitemid 35341439)
4. Zhou QY. The prokineticins: A novel pair of regulatory peptides. Mol Interv. 2006;6:330-338.
5. Negri L, Lattanzi R, Giannini E, Melchiorri P. Bv8/prokineticin proteins and their receptors. Life Sci. 2007;81:1103-1116. (Pubitemid 47444317)
6. Cheng MY, Bullock CM, Li C, et al. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature. 2002;417:405-410. (Pubitemid 34563527)
7. Mollay C, Wechselberger C, Mignogna G, et al. Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats. Eur J Pharmacol. 1999;374:189-196. (Pubitemid 29287133)
8. Zhou QY, Cheng MY. Prokineticin 2 and circadian clock output. FEBS J. 2005;272:5703-5709. (Pubitemid 41689344)
9. Li M, Bullock CM, Knauer DJ, Ehlert FJ, Zhou QY. Identification of two prokineticin cDNAs: Recombinant proteins potently contract gastrointestinal smooth muscle. Mol Pharmacol. 2001;59:692-698. (Pubitemid 32273997)
10. Bullock CM, Li JD, Zhou QY. Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists. Mol Pharmacol. 2004;65:582-588. (Pubitemid 38264025)
11. LeCouter J, Kowalski J, Foster J, et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature. 2001;412:877-884. (Pubitemid 32821726)
12. LeCouter J, Lin R, Tejada M, et al. The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells. Proc Natl Acad Sci USA. 2003;100:2685-2690. (Pubitemid 36297559)
13. Melchiorri D, Bruno V, Besong G, et al. The mammalian homologue of the novel peptide Bv8 is expressed in the central nervous system and supports neuronal survival by activating the MAP kinase/PI-3-kinase pathways. Eur J Neurosci. 2001;13:1694-1702. (Pubitemid 32488059)
14. Matsumoto S, Yamazaki C, Masumoto KH, et al. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc Natl Acad Sci USA. 2006;103:4140-4145.
15. Masumoto KH, Nagano M, Takashima N, et al. Distinct localization of prokineticin 2 and prokineticin receptor 2 mRNAs in the rat suprachiasmatic nucleus. Eur J Neurosci. 2006;23:2959-2970. (Pubitemid 43882875)
16. Schweitz H, Pacaud P, Diochot S, Moinier D, Lazdunski M. MIT(1), a black mamba toxin with a new and highly potent activity on intestinal contraction. FEBS Lett. 1999;461:183-188. (Pubitemid 29533330)
17. LeCouter J, Zlot C, Tejada M, Peale F, Ferrara N. Bv8 and endocrine glandderived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc Natl Acad Sci USA. 2004;101:16813-16818. (Pubitemid 39601321)
18. Martucci C, Franchi S, Giannini E, et al. Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages. Br J Pharmacol. 2006;147:225-234. (Pubitemid 43151571)
19. Shojaei F, Wu X, Zhong C, et al. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature. 2007;450:825-831. (Pubitemid 350231321)
20. Negri L, Lattanzi R, Giannini E, et al. Nociceptive sensitization by the secretory protein Bv8. Br J Pharmacol. 2002;137:1147-1154. (Pubitemid 36071731)
21. Negri L, Lattanzi R, Giannini E, et al. Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: Focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior. J Neurosci. 2006;26:6716-6727. (Pubitemid 44315233)
22. Negri L, Lattanzi R, Giannini E, Melchiorri P. Modulators of pain: Bv8 and prokineticins. Curr Neuropharmacol. 2006;4:207-215.
23. Giannini E, Lattanzi R, Nicotra A, et al. The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain. Proc Natl Acad Sci USA. 2009;106:14646-14651.
24. Balboni G, Lazzari I, Trapella C, et al. Triazine compounds as antagonists at Bv8-prokineticin receptors. J Med Chem. 2008;51:7635-7639.
25. Coats SJ, Dyatkin AB, He W, Lisko J, Ralbovsky JL, Schultz MJ, inventors; Janssen Pharmaceutica, N.V., assignee. Prokineticin 1 receptor antagonists. Patent WO2006104715. October 5, 2006.
26. Coats SJ, Dyatkin AB, He W, Lisko J, Ralbovsky JL, Schultz MJ, inventors; Janssen Pharmaceutica, N.V., assignee. Pyrimidindione derivatives as prokineticin 2 receptor antagonists. Patent WO2006104713. October 5, 2006.
27. Coats SJ, Dyatkin AB, HeW, Lisko J, Miskowski TA, Ralbovsky JL, Schultz MJ, inventors; Janssen Pharmaceutica, N.V., assignee. Prokineticin 2 receptor antagonists. Patent WO2007079214. July 12, 2007.
28. Thompson WJ, Melamed JY, inventors; Merck & Co., assignee. Preparation of morpholinecarboxamides as prokineticin 2 receptor antagonists. Patent WO2007067511. June 14, 2007.
29. Ralbovsky JL, Lisko JG, Palmer JM, et al. Triazinediones as prokineticin 1 receptor antagonists: Part 1-SAR, synthesis and biological evaluation. Bioorg Med Chem Lett. 2009;19:2661-2663.
30. Blower PJ, Lewis JS, Zweit J. Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl Med Biol. 1996;23:957-980. (Pubitemid 27050682)
31. 18F-T140. J Nucl Med. 2010;51:1796-1804.
32. 18F]FAc in a sarcoma- and inflammation- bearing mouse model. Nucl Med Biol. 2009;36:305-312.
33. 18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models. Nucl Med Biol. 2005;32:137-145. (Pubitemid 40260665)
34. 18F-labeled RGD peptide: Initial evaluation for imaging brain tumor angiogenesis. Nucl Med Biol. 2004;31:179-189. (Pubitemid 38315112)
35. 18F-labeled galacto and PEGylated RGD dimers for PET imaging of alphavbeta3 integrin expression. Mol Imaging Biol. 2010;12:530-538.
36. Lakhan SE, Kirchgessner A. Neuroinflammation in inflammatory bowel disease. J Neuroinflammation. 2010;7:37.
37. Basken NE, Green MA. Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: Further definition of species dependence and associated substituent effects. Nucl Med Biol. 2009;36:495-504.
38. Adonai N, Nguyen KN, Walsh J, et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde- bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci USA. 2002;99:3030-3035. (Pubitemid 34240580)